Treatment News : Early PrEP Users Report Reduced Anxiety About HIV Risk

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » June 2014

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


June 17, 2014

Early PrEP Users Report Reduced Anxiety About HIV Risk

Gay men who were among the first to take Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) to prevent HIV reported improved peace of mind over their risk of infection, aidsmap reports. Presenting their findings at the 9th International Conference on HIV Treatment and Prevention Adherence in Miami, researchers interviewed 87 men who participated in iPrEX OLE, the open-label extension phase of the trial that first proved PrEP’s efficacy.

About 70 percent of those interviewed chose to take Truvada, most of whom saw themselves at risk for HIV and were highly motivated to remain HIV negative.

Those taking PrEP reported seeing the therapy as an extra layer of protection and an adjunct to condoms, which they used some or all of the time. They often compared Truvada to other risk-reduction tools such as parachutes or seat belts.

The most common reason for stopping the use of Truvada was because of changes in their personal risk factors: for example, if a man entered into a monogamous relationship with another HIV-negative partner. Some were also fearful of potential side effects. However, few had actual side effects that motivated them to stop taking PrEP.

To read the aidsmap story, click here.

Search: PrEP, pre-exposure prophylaxis, Truvada, emtricitabine, tenofovir, aidsmap, reduced anxiety, peace of mind, HIV.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.